Vemurafenib
B-Raf Serine-Threonine Kinase (Braf) Inhibitors
Sold as Zelboraf
- Drug class
- B-Raf Serine-Threonine Kinase (Braf) Inhibitors
- Availability
- See label
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 3
Overview
Vemurafenib is an active pharmaceutical ingredient in the B-Raf Serine-Threonine Kinase (Braf) Inhibitors group (L01EC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| EU European Union | EMA | 1 | June 19, 2025 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
| GB United Kingdom | MHRA | 1 | December 19, 2025 |
EUEuropean Union· EMA
1 product
Uses
1).
How to take
CACanada· Health Canada
1 product
Uses
AND CLINICAL USE ........................................................................... 3 CONTRAINDICATIONS ............................................................................................... 4 WARNINGS AND PRECAUTIONS ..............................................................................
4 ADVERSE REACTIONS .............................................................................................. 11 DRUG INTERACTIONS .............................................................................................. 19 DOSAGE AND ADMINISTRATION ...........................................................................
22 OVERDOSAGE ............................................................................................................ 24 ACTION AND CLINICAL PHARMACOLOGY .......................................................... 25 STORAGE AND STABILITY .....................................................................................
GBUnited Kingdom· MHRA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].
Drug interactions
Known interactions involving Vemurafenib. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 510. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]European Medicines Agency · EMEA/H/C/002409 · revised June 19, 2025
- [2]Health Canada (DPD) · 02380242 · revised March 22, 2025
- [3]MHRA (UK) · PLPI459850969 · revised December 19, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.